Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection

Lancet

Volumn 350, Issue 9093, 1997, Pages 1738-1742

  Guerrero, Antonio ^a,b   Cobo, Javier ^a   Fortún, Jesús ^a   Navas, Enrique ^a   Quereda, Carmen ^a   Asensio, Angel ^a   Cañón, José ^a   Blazquez, Jesús ^a   Gómez Mampaso, Enrique ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; SPAIN; TUBERCULOSIS;

EID: 0031581504     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07567-3     Document Type: Article

References (28)

1. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resitant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1514-21.
2. Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infection: factors in transmission to staff and HIV-infected patients. JAMA 1992; 268: 1280-86.
3. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992; 117: 191-96.
4. Centers for Diseases Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons, Florida and New York, 1988-1991. Morb Mort Wkly Rep 1991; 40: 585-91.
5. Rullán JV, Herrera D, Cano R, et al. Nosocomial transmission of multidrug-resitant Mycobacterium tuberculosis in Spain. Emerg Infect Dis 1996; 2: 125-29.
6. Bouvet E, Casalino E, Mendoza Sassi G, et al. A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients: a case-control study. AIDS 1993; 7: 1453-60.
7. Communicable Disease Report, United Kingdom PHLS. Outbreak of hospital acquired multidrug resistant tuberculosis. Commun Dis Rep Wkly 1995; 5: 161.
8. Angarano G, Carbonara D, Costa D. Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study: the Italian tuberculosis drug resistance study group. Microbiologica 1995; 18: 69-72.
9. Grange JM, Yates MD. Zoonotic aspects of Mycobacterium bovis infection. Vet Microbiol 1994; 40: 137-51.
10. Morris RS, Pfeiffer DU, Jackson R. The epidemiology of Mycobacterium bovis infections. Vet Microbiol 1994; 40: 153-77.
11. Grange JM, Daborn C, Cosivi O. HIV-related tuberculosis due to Mycobacterium bovis. Eur Res J 1994; 7: 1564-66.
12. Albrecht H, Stellbrink HJ, Eggers C, Rüsch-Gerdes S, Greten H. A case of disseminated Mycobacterium bovis infection in an AIDS patient. Eur J Clin Microbiol Infect Dis 1995; 14: 226-29.
13. Vestal ASM. Procedures for the isolation and identification of Mycobacteria. Washington: Government Printing Office, US Department of Health, Education and Welfare. Publication CDC, 1975.
14. Van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 2834-35.
15. Van Soolingen D, de Haas PE, Haagsma J, et al. Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans for studying epidemiology of bovine tuberculosis. J Clin Microbiol 1994; 32: 2425-33.
16. Blázquez J, Espinosa de los Monteros LE, Samper S, et al. Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol 1997; 35:1390-93.
17. Canetti G, Rist N, Grosset J. Measure de la sensibilité du bacille tuberculeux aux drogues antibacillaires pour la méthode des proportions. Rev Tuberc Pneumo 1963; 27: 263-72.
18. Ikeda RM, Birkhead GS, DiFerdinando GT, et al. Nosocomial tuberculosis: an outbreak of a strain resistant to seven drugs. Infect Control Hosp Epidemiol 1995; 16: 152-59.
19. Bifani PJ, Plikaytis BB, Kapur V, et al. Origin and interstate spread of a New York city multi drug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275: 452-57.
20. Hamburg MA, Frieden TR. Tuberculosis transmission in the 1990s. N Engl J Med 1994; 330: 1750-51.
21. Small PM, Hopewell PC, Singh PS, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-09.
22. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York city: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-16.
23. Danker WM, Waecker NJ, Essey MQ, Moser K, Thompson M, Davis CHE. Mycobacterium bovis infections in San Diego: a clinic epidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine 1993; 72: 11-37.
24. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York city: turning the tide. N Engl J Med 1995; 333: 229-33.
25. Frieden TR, Sherman LF, Maw KL et al. A multi-institutional outbreak of highly drug-resitant tuberculosis: epidemiology and clinical outcomes. JAMA 1996; 276: 1229-35.
26. Blumberg HM, Watkins DL, Berschling JD, et al. Preventing nosocomial transmission of tuberculosis. Ann Intern Med 1995; 122: 658-63.
27. Wenger PN, Otten J, Breeden A, Orfas D, Beck-Sague CM, Jarvis WR. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients. Lancet 1995; 345: 235-40.
28. Centers for Diseases Control and prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Morb Mort Wkly Rep 1994; 43: 131-32.